Methylation status of the CpG islands in vitamin d and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages

  Varshney, Shweta ^a   Bhadada, Sanjay Kumar ^a   Sachdeva, Naresh ^a   Arya, Ashutosh Kumar ^a   Saikia, Uma Nahar ^a   Behera, Arunanshu ^a   Rao, Sudhaker D ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR; GENOMIC DNA; VITAMIN D;

ADULT; ARTICLE; BASE PAIRING; CASR GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARATHYROID ADENOMA; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; VDR GENE;

ADENOMA; ADULT; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING;

EID: 84885212131     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1699     Document Type: Article

References (23)

1. Brown EM. Physiology of calcium metabolism. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. 3rd ed. Philadelphia, PA: Lippincott Williams, Wilkins; 2001: 478-489.
2. Bringhurst FR, Demay MB, Kronenberg HM Hormones and dis-ordersofmineral metabolism. In: Melmed S, Williams RH, Polonsky KS, Larsen PR, kronenberg HM, eds. Williams Textbook of Endocrinology. 12th ed. Philadelphia, PA: Elsevier/Saunders; 2011: 1237-1304.
3. Sudhaker Rao D., Han ZH, Phillips E.R., Palnitkar S., Parfitt AM Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clin Endocrinol (Oxf). 2000; 53: 373-381.
4. Carling T, Rastad J, Szabó E, Westin G, Akerström G. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab. 2000; 85: 2000-2003.
5. Yano S, Sugimoto T, Tsukamoto T., et al Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas. Eur J Endocrinol. 2003; 148: 403-411.
6. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab. 1996; 81: 1598-1606.
7. Farnebo F, Enberg U, Grimelius L., et al Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab. 1997; 82: 3481-3486.
8. Gogusev J, Duchambon P, Hory B., et al Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 1997; 51: 328-336.
9. Garner SC, Hinson TK, McCarty K.S., Leight M., Leight GS Jr, Quarles LD. Quantitative analysis of the calcium-sensing receptor messenger RNA in parathyroid adenomas. Surgery. 1997; 122: 1166-1175.
10. Varshney S, Bhadada SK, Saikia U.N., et al Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians. Eur J Endocrinol. 2013; 169: 109-116.
11. Samander EH, Arnold A. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas. J Clin Endocrinol Metab. 2006; 91: 5019-5021.
12. Cetani F, Pinchera A, Pardi E., et al No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res. 1999; 14: 878-882.
13. Frey FJ. Methylation of CpG islands: potential relevance for hypertension and kidney diseases. Nephrol Dial Transplant. 2005; 20: 868-869.
14. Bird A. Perceptions of epigenetics. Nature. 2007; 447: 396-398.
15. Haussler MR, Whitfield GK, Haussler C.A., et al The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998; 13: 325-349.
16. Chikatsu N, Fukumoto S, Takeuchi Y., et al Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas. J Biol Chem. 2000; 275: 7553-7557.
17. Hizaki K, Yamamoto H, Taniguchi H., et al Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. Mod Pathol. 2011; 24: 876-884.
18. Marik R, Fackler M, Gabrielson E., et al DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biol Ther. 2010; 10: 44-53.
19. T Method. Methods. 2001; 25: 402-408.
20. Hofman-Bang J., Gravesen E, Olgaard K., Lewin E. Epigenetic methylation of parathyroid CaR and VDR promoters in experimental secondary hyperparathyroidism. Int J Nephrol. 2012; 2012: 123576.
21. Miyamoto K, Kesterson RA, Yamamoto H, et al Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997; 11: 1165-1179.
22. Varley KE, Gertz J, Bowling K.M., et al Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 2013; 23: 555-567.
23. Heintzman ND, Ren B. Finding distal regulatory elements in the human genome. Curr Opin Genet Dev. 2009; 19: 541-549.